Investment to Enhance Global MRI Efficiency
AIRS Medical has announced a strategic investment from TA Associates to accelerate the global growth of its AI-driven MRI solutions. This investment aims to enhance imaging efficiency and expand patient access at healthcare providers worldwide.
Founded in 2018, AIRS Medical is based in Hong Kong and Seoul. The company develops AI-native MRI software that improves speed, image quality, and workflow. More than 1,700 healthcare institutions in over 40 countries have adopted their technologies. Every year, these AI technologies are used in over 6 million MRI examinations.
“MRI scanners are among the most valuable assets in healthcare, yet many providers continue to struggle with growing imaging demand and limited capacity,” said Dr. Hyeseong Lee, Co-Founder and Chairman of AIRS Medical. He emphasised the importance of the new investment in addressing these challenges.
Advancing AI in Medical Imaging
The investment will support the advancement of AIRS Medical’s AI-powered solutions, such as SwiftMR® and SwiftSight®. These solutions provide a comprehensive approach from image acquisition to clinical interpretation. Their widespread use highlights their critical role in modern healthcare.
CEO Jason Park stated, “With TA’s support, we will accelerate product innovation and expand our international footprint.” The transaction is expected to close in the second quarter of 2026. This partnership marks a significant phase in AIRS Medical’s mission to improve MRI efficiency and expand access to advanced diagnostics globally.
Healthcare organisations and academic institutions are increasingly adopting AIRS Medical’s technologies to expand imaging capacity and improve patient access. As AIRS Medical continues to innovate, it remains uniquely positioned at the intersection of AI, medical imaging, and healthcare operations.
Edward Sippel, Managing Director and head of TA Asia Pacific, remarked, “As an AI-native medical technology leader, AIRS Medical has developed a differentiated AI platform that addresses critical capacity and workflow challenges facing radiology providers globally.” His comments underscore the investment’s potential to enhance the company’s global impact.
AIRS Medical plans to leverage this investment to further product innovation, broaden international presence, and help healthcare providers unlock greater value from existing MRI infrastructure. This strategic move aims to support the increasing global demand for efficient medical imaging solutions.
Last updated: 29 June 2026, 11:49 am
